Ajanta Pharma Ltd Annually Results

Gross Sales

4,208.71

3,742.64

3,340.99

2,889.69

2,587.87

Excise Duty

0

0

0

0

0

Net Sales

4,208.71

3,742.64

3,340.99

2,889.69

2,587.87

Other Operating Income

0

0

0

0

0

Other Income

84.6

98.64

115.68

25.98

92.19

Total Income

4,293.31

3,841.28

3,456.67

2,915.67

2,680.06

Total Expenditure

3,036.77

2,959.39

2,411.69

1,891.13

1,908.46

PBIDT

1,256.54

881.89

1,044.98

1,024.54

771.6

Interest

7.21

5.84

10.2

8.27

11.91

PBDT

1,249.33

876.05

1,034.78

1,016.27

759.69

Depreciation

135.4

130.8

125.3

116.09

95.72

Minority Interest Before NP

0

0

0

0

0

Tax

322.06

197.24

191.67

261.36

186.35

Deferred Tax

-24.3

-39.97

5.13

-15.05

9.92

Reported Profit After Tax

816.17

587.98

712.68

653.87

467.7

Minority Interest After NP

0

0

0

0

0

Net Profit after Minority Interest

816.17

587.98

712.68

653.87

467.7

Extra-ordinary Items

0

0

0

0

-2.76

Adjusted Profit After Extra-ordinary item

816.17

587.98

712.68

653.87

470.46

EPS (Unit Curr.)

64.82

49.89

54.97

75.09

53.6

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

2,550

350

475

475

650

Equity

25.27

25.27

17.17

17.39

17.54

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

29.85

23.56

31.27

35.45

29.81

PBDTM(%)

29.68

23.4

30.97

35.16

29.35

PATM(%)

19.39

15.71

21.33

22.62

18.07